Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Carcinoma × niraparib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 10 Prostatic Neoplasms 3 Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Neoplasm Metastasis 2 Fallopian Tube Neoplasms 2 Brain Neoplasms 2 Advanced Solid Tumor 2 Triple Negative Breast Neoplasms 1 SCLC,Extensive Stage 1 Rare Tumor 1 Penile Neoplasms 1 Pathologic Complete Response 1 Pancreatic Adenocarcinoma Metastatic 1 Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma 1 Ovarian Carcinosarcoma 1 Oropharyngeal Neoplasms 1 Mouth Neoplasms 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Laryngeal Diseases 1 Hemangiosarcoma 1 Glioblastoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma 1 Biliary Tract Neoplasms 1

Interventions

Cisplatin 11 pembrolizumab 10 Specimen Handling 7 Magnetic Resonance Spectroscopy 7 Platinum 4 Pemetrexed 4 Paclitaxel 4 Cyclophosphamide 4 1,2-diaminocyclohexaneplatinum II citrate 4 fludarabine 3 durvalumab 3 Radiotherapy, Intensity-Modulated 3 Radiotherapy 3 Oxaliplatin 3 Nivolumab 3 Fluorouracil 3 Carboplatin 3 osimertinib 2 cabozantinib 2 atezolizumab 2 Heavy Ion Radiotherapy 2 Gemcitabine 2 Drug Therapy 2 Docetaxel 2 Cetuximab 2 Capecitabine 2 Biopsy 2 zipalertinib 1 trastuzumab deruxtecan 1 tocilizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06827353 2025-02-14

OVNI-B

Centre Hospitalier Universitaire de Nīmes

Carcinoma, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡